Renowned biotechnology executive and former Alnylam CEO John Maraganore has joined Evox Therapeutics Ltd as an advisor. The company said – ‘We look forward to his counsel as we advance our…
Read More
Enara Bio announces the appointment of T-cell therapy leader Dr. Sophie Papa as Chief Medical Officer Oxford, UK – 1st February 2022. Enara Bio, a biotechnology company advancing novel T-cell receptor…
Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered Medicines January 7, 2022 * Collaborative efforts aim to accelerate drug discovery and improve clinical success *…
Oxford Cancer Biomarkers appoints Joanna Smart as Chair of the Board OXFORD, UK – 6th January 2022 – Joanna Smart, an experienced Director and CEO in the life sciences sector has been…
First Patient Dosed in Ground-Breaking Clinical Investigation for OxSonics Therapeutics Oxford, UK – 5th January 2022 – OxSonics® Therapeutics, a world leader in the development of ultrasound-based drug delivery systems…
Sensyne Health announces one year agreement with Exscientia to utilise real-world data platform Agreement includes an upfront payment for four SENSIGHT subscriptions and associated professional services Oxford, U.K. – 24th December…
OrganOx receives FDA approval for metra device OrganOx, a world leader in normothermic machine perfusion (NMP), today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of…
Oxford, UK – 10 November 2021 – Sitryx (“the Company”), a biopharmaceutical company focused on regulating cell metabolism to develop disease-modifying therapeutics in immuno-inflammation and immuno-oncology, today announces the appointment…
OMass Unveils Rich Drug Discovery Pipeline Targeting Intractable or Inadequately Drugged Membrane and Complex-bound Proteins Oxford, United Kingdom – 4 November 2021 – OMass Therapeutics (‘OMass’ or ‘the Company’), a…
Acquisition of ATDBio by Biotage AB to provide platform for further growth Founders look forward to continued focus on customers and innovation Oxford and Southampton, UK, October 20 2021 –…
Scancell expands its R&D capabilities with new facilities at The Oxford Science Park Oxford, UK, 19 October 2021 – Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for…
LANDMARK PAPER HIGHLIGHTS EVOX THERAPEUTICS’ CUTTING EDGE EXOSOME ENGINEERING APPROACH FOR ENHANCED SURFACE DISPLAY OF BIOLOGICS Evox’s engineered exosomes show better efficacy compared to conventional biologics and significantly outperformed other…
Vatic announces manufacturing partnership with Abingdon Health Abingdon Health plc (“Abingdon Health”), a leading international developer and manufacturer of high quality and effective rapid tests, and Vatic Health Limited (“Vatic”),…
OXFORD, England–(BUSINESS WIRE)– Exscientia plc (Nasdaq: EXAI), an AI-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner, today announced the…
Physiomics plc (AIM: PYC), the consultancy using mathematical models to support the development of drug treatment regimens and personalised medicine solutions is pleased to announce its PARTNER study has recruited…